These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16505690)

  • 1. Extracorporeal cytokine apheresis for sepsis: CTR as a new therapeutic adsorbent.
    Shimizu T; Endo Y; Tani T
    Crit Care Med; 2006 Mar; 34(3):926-7. PubMed ID: 16505690
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel adsorbent of circulating bacterial toxins and cytokines: the effect of direct hemoperfusion with CTR column for the treatment of experimental endotoxemia.
    Taniguchi T; Hirai F; Takemoto Y; Tsuda K; Yamamoto K; Inaba H; Sakurai H; Furuyoshi S; Tani N
    Crit Care Med; 2006 Mar; 34(3):800-6. PubMed ID: 16521274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a new extracorporeal system using CTR on mortality and inflammatory responses to bacterial toxin-induced multiple organ dysfunction syndrome in rabbits.
    Kawatsu M; Wada J; Kitano M; Ogino E; Sakurai H; Furuyoshi S; Tani N
    Blood Purif; 2006; 24(3):327-34. PubMed ID: 16534195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity.
    Kojika M; Sato N; Yaegashi Y; Suzuki Y; Suzuki K; Nakae H; Endo S
    Ther Apher Dial; 2006 Feb; 10(1):12-8. PubMed ID: 16556131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine adsorptive property of various adsorbents in immunoadsorption columns and a newly developed adsorbent: an in vitro study.
    Oda S; Hirasawa H; Shiga H; Nakanishi K; Matsuda K; Nakamura M; Ikeda H; Sakai M
    Blood Purif; 2004; 22(6):530-6. PubMed ID: 15583478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonmenstrual toxic shock syndrome: new insights into diagnosis, pathogenesis, and treatment.
    Parsonnet J
    Curr Clin Top Infect Dis; 1996; 16():1-20. PubMed ID: 8714246
    [No Abstract]   [Full Text] [Related]  

  • 7. Dynamics of elimination of bacterial endotoxins and cytokines from the blood of tumor patients with sepsis in hemoperfusion using carbon adsorbents.
    Anisimova NY; Gromova EG; Kuznetsova LS; Sitdikova SM; Kiselevskii MV
    Bull Exp Biol Med; 2011 Sep; 151(5):622-4. PubMed ID: 22462061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of extracorporeal treatment with Lixelle on the mortality and inflammatory responses to endotoxin-induced shock in rats.
    Tsuda K; Taniguchi T
    Ther Apher Dial; 2006 Feb; 10(1):49-53. PubMed ID: 16556136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [INFLUENCE OF EXTRACORPOREAL DETOXIFICATION METHODS ON TISSUE PERFUSION IN SEPTIC SHOCK].
    Khoroshilov SE; Nikulin AV; Bazhina ES
    Anesteziol Reanimatol; 2015; 60(5):65-7. PubMed ID: 26852583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoperfusion for the treatment of poisoning: technology, determinants of poison clearance, and application in clinical practice.
    Ghannoum M; Bouchard J; Nolin TD; Ouellet G; Roberts DM
    Semin Dial; 2014; 27(4):350-61. PubMed ID: 24823936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of infectious-inflammatory urologic diseases and their complications by efferent detoxication methods].
    Lopatkin NA; Danilkov AP; Kozlov VA; Chudnovskaia MV; Khalatov AS; Siniukhin VN; Perepanova TS
    Urol Nefrol (Mosk); 1990; (4):3-9. PubMed ID: 2275057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-related effects of direct hemoperfusion using a cytokine adsorbent column for the treatment of experimental endotoxemia.
    Taniguchi T; Kurita A; Mukawa C; Yamamoto K; Inaba H
    Intensive Care Med; 2007 Mar; 33(3):529-33. PubMed ID: 17160419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of HA330 hemoperfusion adsorbent method on inflammatory markers and end-organ damage levels in sepsis: a retrospective single center study.
    Erkurt MA; Sarici A; Özer AB; Kuku I; Biçim S; Aydogan MS; Kose A; Memisoglu F; Ince V; Otan E; Kaya E; Berber I; Özgül M; Keser MF
    Eur Rev Med Pharmacol Sci; 2022 Nov; 26(21):8112-8117. PubMed ID: 36394761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal Sorbent Technologies: Basic Concepts and Clinical Application.
    Clark WR; Ferrari F; La Manna G; Ronco C
    Contrib Nephrol; 2017; 190():43-57. PubMed ID: 28535518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoadsorption therapy for sepsis syndromes.
    Kellum JA
    Crit Care Med; 2003 Jan; 31(1):323-4. PubMed ID: 12545045
    [No Abstract]   [Full Text] [Related]  

  • 16. Endotoxin apheresis for sepsis.
    Shimizu T; Endo Y; Tsuchihashi H; Akabori H; Yamamoto H; Tani T
    Transfus Apher Sci; 2006 Dec; 35(3):271-82. PubMed ID: 17118710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyxin B-immobilized fiber improves hyperdynamic state in MRSA septic patients.
    Kawamata T; Imaizumi H; Yoshida M; Kaneko M
    Intensive Care Med; 1997 Jan; 23(1):130-1. PubMed ID: 9037658
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on direct hemoperfusion by activated charcol in endotoxin shock (author's transl)].
    Ebata T; Kobayashi K; Denno R; Totsuka M; Hayasaka H
    Masui; 1980 Jun; 29(6):542-6. PubMed ID: 7401298
    [No Abstract]   [Full Text] [Related]  

  • 19. [Extracorporeal, activated charcoal hemoperfusion in experimental endotoxic shock in dogs].
    Bende S; Bertók L; Kolláth Z
    Orv Hetil; 1985 Mar; 126(9):515-8. PubMed ID: 3991190
    [No Abstract]   [Full Text] [Related]  

  • 20. Sorbent hemoperfusion in end-stage renal disease: an in-depth review.
    Winchester JF
    Adv Ren Replace Ther; 2002 Jan; 9(1):19-25. PubMed ID: 11927903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.